Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Conatus Pharmaceuticals Inc

+ Add to Watchlist

CNAT:US

5.3500 USD 0.1800 3.48%

As of 20:10:00 ET on 05/27/2015.

Company Profile for Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals, Inc. develops therapeutics to treat liver disease. The Company offers drugs to control programmed cell death that contributes to a range of liver diseases and cancer treatments. Conatus Pharmaceuticals provides its products in the United States.

Contact Information

Conatus Pharmaceuticals Inc

16745 West Bernardo Drive
Suite 200
San Diego, CA 92127
United States
Phone: 1-858-376-2600

Key Executives for Conatus Pharmaceuticals Inc (CNAT)

Steven J MentoPresident/CEO/Co-FounderCharles J CashionSenior VP:Finance/CFO/Secy
Alfred P SpadaSenior VP:R&D/Chief Scientific OfcrDaniel L Ripley "Dan"Senior Dir/Head:Corporate Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil